The study is among the first known global examples of an operator-developed mobile health product that has successfully produced significant health benefits in a scientific research carried out by a leading medical institution. According to the results announced by project coordinator Dr. Ilhan Satman, Head of Endocrinology and Metabolic Diseases Division at Istanbul University's Faculty of Medicine; Decrease in 3-month blood sugar exceeds drug benefit threshold The study was carried out with 200 diabetes patients who were divided into 2 groups.